Aussies produce fertility pill for men

Oct 23, 2006

Australian researchers have discovered that a combination of anti-oxidants and vitamins can significantly increase a man's fertility.

The head of the research unit at Adelaide University, Dr. Kelton Tremellen, said that a tablet containing vitamins C and E, folate, zinc, lycopene and garlic oil has been found to help protect a man's sperm from damage caused by smoking and infection.

He told the Australian Broadcasting Corporation that his study showed successful pregnancies doubled among infertile couples after they took the pill.

Tremellen said while infertility often has been seen as a women's issue, infertility in men accounts for more than 50 percent of in-vitro fertilization treatments, the Australian Broadcasting Corporation reported.

Copyright 2006 by United Press International

Explore further: Zogenix says former obesity drug reduced seizures in study

Related Stories

Galapagos volcano calms, pink iguanas out of danger

19 minutes ago

A volcano in the Galapagos Islands whose fiery eruption raised fears for the world's only population of pink iguanas has calmed, sparing the unique critters from danger, officials said Tuesday.

On-demand X-rays at synchrotron light sources

33 minutes ago

Consumers are now in the era of "on-demand" entertainment, in which they have access to the books, music and movies they want thanks to the internet. Likewise, scientists who use synchrotron light sources ...

New chip makes testing for antibiotic-resistant bacteria faster, easier

38 minutes ago

We live in fear of 'superbugs': infectious bacteria that don't respond to treatment by antibiotics, and can turn a routine hospital stay into a nightmare. A 2015 Health Canada report estimates that superbugs have already cost Canadians $1 billion, and are a "serious and growing issue." Each year two million people in the U.S. contract antibiotic-re ...

Recommended for you

US appeals court upholds delay in Alzheimer's drug swap

May 22, 2015

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.